93P Cetuximab-based chemotherapy after progression on immune-checkpoint inhibitors in recurrent/metastatic head and neck squamous cell cancer

Autor: Cabezas-Camarero, S., Sotelo Lezama, M.J., Merino-Menéndez, S., Cabrera-Martín, M.N., Pérez Segura, P.
Zdroj: In Immuno-Oncology and Technology December 2022 16 Supplement 1
Databáze: ScienceDirect